250 related articles for article (PubMed ID: 31241180)
1. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A
Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Nakayama M; Morimoto J; Ito Y; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Iwata T; Matsubara H; Ohara O; Yoshino I; Kaneda A
Int J Cancer; 2021 Jun; 148(12):3008-3018. PubMed ID: 33533494
[TBL] [Abstract][Full Text] [Related]
3. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
4. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
5. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
6. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.
Khan KA; Kennedy MP; Moore E; Crush L; Prendeville S; Maher MM; Burke L; Henry MT
Lung; 2015 Feb; 193(1):71-7. PubMed ID: 25381634
[TBL] [Abstract][Full Text] [Related]
7. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
8. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
10. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
[TBL] [Abstract][Full Text] [Related]
11. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
12. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
13. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
Lee T; Park JY; Lee HY; Cho YJ; Yoon HI; Lee JH; Jheon S; Lee CT; Park JS
Respir Med; 2014 Oct; 108(10):1549-55. PubMed ID: 25175479
[TBL] [Abstract][Full Text] [Related]
16. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
17. Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma.
Ito Y; Usui G; Seki M; Fukuyo M; Matsusaka K; Hoshii T; Sata Y; Morimoto J; Hata A; Nakajima T; Rahmutulla B; Kaiho T; Inage T; Tanaka K; Sakairi Y; Suzuki H; Yoshino I; Kaneda A
Cancer Sci; 2023 Jul; 114(7):3003-3013. PubMed ID: 37082886
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
Tzouvelekis A; Karampitsakos T; Gomatou G; Bouros E; Tzilas V; Manali E; Tomos I; Trachalaki A; Kolilekas L; Korbila I; Tomos P; Chrysikos S; Gaga M; Daniil Z; Bardaka F; Papanikolaou IC; Euthymiou C; Papakosta D; Steiropoulos P; Ntolios P; Tringidou R; Papiris S; Antoniou K; Bouros D
Pulm Pharmacol Ther; 2020 Feb; 60():101880. PubMed ID: 31874284
[TBL] [Abstract][Full Text] [Related]
20. Global methylation patterns in idiopathic pulmonary fibrosis.
Rabinovich EI; Kapetanaki MG; Steinfeld I; Gibson KF; Pandit KV; Yu G; Yakhini Z; Kaminski N
PLoS One; 2012; 7(4):e33770. PubMed ID: 22506007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
